• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经桡动脉介入治疗后桡动脉闭塞时最小压力与专利止血法的比较。

Comparison of Minimum Pressure and Patent Hemostasis on Radial Artery Occlusion After Transradial Catheterization.

机构信息

Instituto de Cardiologia de Santa Catarina, Rua Adolfo Donato da Silva, s/n. Praia Comprida, São José, Santa Catarina. CEP 88103-901.

出版信息

J Invasive Cardiol. 2020 Apr;32(4):147-152. doi: 10.25270/jic/19.00372. Epub 2020 Mar 11.

DOI:10.25270/jic/19.00372
PMID:32160152
Abstract

OBJECTIVES

The aim of this study was to compare two hemostatic techniques, minimum pressure technique and patent hemostasis, on radial artery occlusion (RAO) after transradial catheterization.

BACKGROUND

RAO is an infrequent complication of transradial procedures. One of the strategies used to reduce this complication is the patent hemostasis technique. Use of minimum pressure in hemostatic wristband, without monitoring patency, might have the same efficacy for preventing RAO.

METHODS

This is a multicenter study encompassing patients submitted to transradial catheterization. After pneumatic wristband application, the band was deflated to the lowest allowable volume while preserving hemostasis. Radial artery patency was subsequently evaluated. The group with no return of plethysmographic curve was labeled "minimum pressure," and the group in which the signal returned was labeled "patent hemostasis." RAO was verified by Doppler evaluation within the first 24 hours of the procedure.

RESULTS

A total of 1082 patients were enrolled, with mean age of 61.4 ± 10.4 years. The majority (61.0%) were male and 34.5% had diabetes. Patent hemostasis was achieved in only 213 cases (20%). Early RAO occurred in 16 patients (1.8%) in the minimum pressure group and in 4 patients (1.9%) in the patent hemostasis group (P=.97). No major bleeding was observed among the entire cohort. EASY scale for hematoma grade was similar between the cohorts (EASY grades 1-3: 7.0% in the minimum pressure group vs 7.5% in the patent hemostasis group; P=.96).

CONCLUSION

Checking radial patency during hemostatic compression may not be necessary after the procedure when adopting a mild and short hemostatic compression.

摘要

目的

本研究旨在比较两种止血技术,即最小压力技术和专利止血技术,对经桡动脉穿刺后桡动脉闭塞(RAO)的影响。

背景

RAO 是经桡动脉介入治疗的一种罕见并发症。减少这种并发症的策略之一是专利止血技术。在止血腕带中使用最小压力,而不监测通畅性,可能同样有效预防 RAO。

方法

这是一项多中心研究,纳入了接受经桡动脉导管插入术的患者。气动腕带应用后,在保持止血的同时将腕带放气至最低允许体积。随后评估桡动脉通畅性。无容积描记曲线恢复的组标记为“最小压力”,信号恢复的组标记为“专利止血”。在操作后的 24 小时内通过多普勒评估验证 RAO。

结果

共纳入 1082 例患者,平均年龄为 61.4 ± 10.4 岁。大多数(61.0%)为男性,34.5%患有糖尿病。仅 213 例(20%)实现了专利止血。最小压力组中有 16 例(1.8%)和专利止血组中有 4 例(1.9%)发生早期 RAO(P=.97)。整个队列中均未观察到大出血。两组的 EASY 血肿分级相似(EASY 分级 1-3:最小压力组为 7.0%,专利止血组为 7.5%;P=.96)。

结论

在采用轻度和短暂的止血压迫时,在止血过程中检查桡动脉通畅性可能不是必需的。

相似文献

1
Comparison of Minimum Pressure and Patent Hemostasis on Radial Artery Occlusion After Transradial Catheterization.经桡动脉介入治疗后桡动脉闭塞时最小压力与专利止血法的比较。
J Invasive Cardiol. 2020 Apr;32(4):147-152. doi: 10.25270/jic/19.00372. Epub 2020 Mar 11.
2
Prevention of radial artery occlusion-patent hemostasis evaluation trial (PROPHET study): a randomized comparison of traditional versus patency documented hemostasis after transradial catheterization.桡动脉闭塞预防-通畅止血评估试验(PROPHET研究):经桡动脉导管插入术后传统止血与记录通畅性止血的随机对照比较
Catheter Cardiovasc Interv. 2008 Sep 1;72(3):335-340. doi: 10.1002/ccd.21639.
3
Comparison of a priori versus provisional heparin therapy on radial artery occlusion after transradial coronary angiography and patent hemostasis (from the PHARAOH Study).经桡动脉冠状动脉造影和止血有效后桡动脉闭塞的肝素预先治疗与临时治疗的比较(来自 PHARAOH 研究)。
Am J Cardiol. 2012 Jul 15;110(2):173-6. doi: 10.1016/j.amjcard.2012.03.007. Epub 2012 Apr 10.
4
Prevention of Radial Artery Occlusion After Transradial Catheterization: The PROPHET-II Randomized Trial.经桡动脉入路导管介入术后预防桡动脉闭塞:PROPHET-II 随机试验。
JACC Cardiovasc Interv. 2016 Oct 10;9(19):1992-1999. doi: 10.1016/j.jcin.2016.07.020.
5
Facilitated patent haemostasis after transradial catheterisation to reduce radial artery occlusion.经桡动脉导管插入术后促进有效止血以减少桡动脉闭塞。
EuroIntervention. 2015 Nov;11(7):765-71. doi: 10.4244/EIJV11I7A153.
6
Effect of duration of hemostatic compression on radial artery occlusion after transradial access.经桡动脉入路止血压迫时间对桡动脉闭塞的影响。
Catheter Cardiovasc Interv. 2012 Jan 1;79(1):78-81. doi: 10.1002/ccd.22963. Epub 2011 May 16.
7
Randomized Trial of Compression Duration After Transradial Cardiac Catheterization and Intervention.经桡动脉心脏导管插入术及介入治疗后压迫持续时间的随机试验
J Am Heart Assoc. 2017 Feb 3;6(2):e005029. doi: 10.1161/JAHA.116.005029.
8
Randomized COmparison of Isolated Radial Artery ComPrEssioN Versus Radial and Ipsilateral Ulnar Artery Compression in Achieving Radial Artery Patency: The OPEN-Radial Trial.孤立桡动脉压迫与桡动脉及同侧尺动脉压迫在实现桡动脉通畅方面的随机对照比较:开放式桡动脉试验
J Invasive Cardiol. 2020 Dec;32(12):476-482. doi: 10.25270/jic/20.00310. Epub 2020 Sep 22.
9
Effect of hemostatic device on radial artery occlusion: A randomized comparison of compression devices in the radial hemostasis study.止血装置对桡动脉闭塞的影响:桡动脉止血研究中压迫装置的随机比较。
Cardiovasc Revasc Med. 2018 Dec;19(8):934-938. doi: 10.1016/j.carrev.2018.08.013. Epub 2018 Aug 23.
10
Accelerated patent hemostasis using a procoagulant disk; a protocol designed to minimize the risk of radial artery occlusion following cardiac catheterization.使用促凝盘加速专利止血;一种旨在将心脏导管插入术后桡动脉闭塞风险降至最低的方案。
Cardiovasc Revasc Med. 2019 Feb;20(2):137-142. doi: 10.1016/j.carrev.2018.03.026. Epub 2018 Apr 21.